Deep Medicine Acquisition... (DMAQ)
NASDAQ: DMAQ
· Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM
Deep Medicine Acquisition Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
Fiscal Year | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -2.67M | -8.84M | 577.35K | -270.35K | -261.56K | -657.6K | 577.35K | -165.56K | -154.42K | -183.35K | -135.42K | -78.77K | -16.5K |
Depreciation & Amortization | 203.65K | 639.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | n/a | 4.36M | -577.35K | -90.69K | -110.53K | -95.76K | -1.06M | -552.16K | -115.41K | 6.32K | -2.18K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -410.46K | n/a | 91.86K | 318.6K | 386.72K | 176.4K | 524.42K | 100.71K | 76.94K | -286.57K | -92.57K | 14.25K |
Operating Cash Flow | -449.12K | -4.25M | 577.35K | -269.17K | -53.5K | -366.64K | -307.37K | -193.3K | -169.12K | -100.1K | -424.17K | -171.34K | -2.25K |
Capital Expenditures | -64.16K | -36.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 2.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -270.53K | -4.42M | n/a | 2.91M | -200K | 120.93M | -510.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -334.69K | -1.97M | n/a | 2.91M | -200K | 120.93M | -510.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -121.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.52M | 24.64M | 12.51M | -2.83M | 200K | -120.93M | 1.26M | n/a | n/a | n/a | 128.84M | n/a | n/a |
Financial Cash Flow | 2.52M | -1.14M | 12.51M | -2.83M | 200K | -120.93M | 1.26M | 13.27M | n/a | n/a | 128.84M | n/a | n/a |
Net Cash Flow | 1.73M | -2.2M | 13.09M | -184.56K | -53.5K | -366.64K | 447.5K | -193.3K | -169.12K | -100.1K | 650.83K | -171.44K | -2.25K |
Free Cash Flow | -513.28K | -4.29M | 577.35K | -269.17K | -53.5K | -366.64K | -307.37K | -193.3K | -169.12K | -100.1K | -424.17K | -171.34K | -2.25K |